Evidence map›Paper›PMID 34071288›Full record

ArticleMarine drugs2021

New Isocoumarin Analogues from the Marine-Derived Fungus

Xiuli Xu, Jiangpeng Li, Kai Zhang, Shangzhu Wei, Rui Lin, Steven W Polyak, Na Yang, Fuhang Song

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. MarineMarine drugs · 2023
    Review
  5. Review
  6. Marine Compounds with Anti-Journal of fungi (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Xiuli XuSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Jiangpeng LiSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Kai ZhangSchool of Light Industry, Beijing Technology and Business University, Beijing 100048, China.
Shangzhu WeiSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Rui LinSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Steven W PolyakUniSA Clinical and Health Sciences, University of South Australia, Adelaide 5005, Australia.ORCID 0000-0002-8458-5194
Na YangCAS Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China.
Fuhang SongSchool of Light Industry, Beijing Technology and Business University, Beijing 100048, China.ORCID 0000-0002-9162-3355
China University of Geosciences (Beijing) · CNBeijing Technology and Business University · CNChinese Academy of Sciences · CNUniversity of South Australia · AU

Funding

Research Foundation for Advanced Talents of Beijing Technology and Business University No. 19008020158the Key Lab of Marine Bioactive Substance and Modern Analytical Technique, SOA MBSMAT-2019-06the National Key R&D Program of China 2018YFC0311000the National Natural Science Foundation of China 81973204
6 · The paper itself

Abstract

Nine new secondary metabolites, including six isocoumarin analogues, 7-hydroxyoospolactone (

Indexed as

Anti-Infective AgentsIsocoumarinsAscomycotaCandida albicansFermentationMicrobial Sensitivity TestsMolecular StructureSecondary MetabolismStaphylococcus aureusAnti-Infective AgentsIsocoumarinsantibacterial activityisocoumarin derivativesmarine-derived fungusnatural productsParaphoma sp.

Identifiers

PMID34071288
PMCPMC8227774
OpenAlexW3165025249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.